GlycoDisplay ApS
PrivateLast Round
Seed
Nov 30, 2016
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GlycoDisplay ApS is a biotechnology company that develops novel biopharmaceuticals by modifying sugars using proprietary targeted cell engineering technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlycoDisplay ApS Comparables
Compare GlycoDisplay ApS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GlyTech, Inc. | 84% | |
| CD BioGlyco | 83% | |
| GlycoT Therapeutics | 81% | |
GlycoDisplay ApS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 30, 2016 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 31% MoM.
- Apr 7, 2026
Monthly visitors increased 57% MoM.
GlycoDisplay ApS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GlycoDisplay ApS's valuation, stock price, and market status.